Institutional investors purchased a net $5.5 million shares of ATHX during the quarter ended June 2016 and now own 17.78% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HUDSON VALLEY INVESTMENT ADVISOR... Bought 22.5 Thousand shares of Athersys Inc